![Lyn Baranowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lyn Baranowski
Vorstandsvorsitzender bei Avalyn Pharma, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Mark W. Surber | M | - |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 13 Jahre |
Mir Imran | M | 67 |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | 12 Jahre |
Lisa Rometty | F | 56 |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | 2 Jahre |
Jonathan Leff | M | 66 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 7 Jahre |
Mir Hashim | M | 65 |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | - |
Talat Imran | M | 43 |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | - |
Susan Blum | F | 52 | 8 Jahre | |
David Malek | M | 47 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | - |
Arvinder Dhalla | M | - |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | - |
Mohsen Shirazi | M | - |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | - |
Ming Cheah | M | - |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 2 Jahre |
Melissa Rhodes | M | - |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 1 Jahre |
Svai Sanford | M | 54 |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | - |
Laureen DeBuono | M | 66 |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | - |
Maulik Nanavaty | M | 62 |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | 8 Jahre |
Sofia Ioannidou | M | 45 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | - |
Jean-Luc Butel | M | 67 |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | - |
Ketan Patel | M | 49 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 7 Jahre |
Tiba Aynechi | M | 48 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 7 Jahre |
Andrew Farquharson | M | 55 |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | - |
Peter Moldt | M | 65 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | - |
Dennis Ausiello | M | 78 |
Rani Therapeutics LLC
![]() Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | 6 Jahre |
Heather Elizabeth Preston | M | 58 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 7 Jahre |
Niall O'Donnell | M | 51 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 7 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Daniel Wechsler | M | 56 | 1 Jahre | |
Kevin Thomas Ferro | M | 53 | 2 Jahre | |
Alan Montgomery | M | 70 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 5 Jahre |
Cecilia Gonzalo | F | 49 | 3 Jahre | |
Thomas Paul Koestler | M | 72 | - | |
John D. Bluth | M | - | - | |
Lisa M. DeFrancesco | F | 45 | 3 Jahre | |
David Zaccardelli | M | 59 | 4 Jahre | |
Jay Galeota | M | 57 | 3 Jahre | |
Ryan Lococo | M | 42 | - | |
Marc R. Schneebaum | M | 69 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 3 Jahre |
Juliet Agranoff | F | - | - | |
Kate Farrington | F | - | 1 Jahre | |
Michael McGuire | M | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 38 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Lyn Baranowski
- Persönliches Netzwerk